HCLSIG/PharmaOntology/Ontology
< HCLSIG | PharmaOntology
Translational Medicine Ontology
The most current version of the ontology is available from the Google code project.
Early Work
Through analysis of the role wiki page and face-to-face discussions, we identified types and relations most relevant to the TMO.
Types
- ActiveIngredient
- Activity
- AdverseEvent
- Amount *
- AnimalStudy
- Antibody
- Assay *
- BioProcess *
- Bioassay
- Bioinformatics
- Biologic
- Biomarker
- ChemicalProperty
- ChemicalSimilarity *
- Cheminformatics
- ClinicalTrial
- Clinician
- Company
- Competitor
- ComplexFormation *
- Compound *
- Diagnosis
- DifferentialDiagnosis
- Discipline
- Disease *
- DiseaseSymptoms
- Dosage
- Dose *
- Drug
- DrugMetabolizingEnzyme *
- DrugNonDrugInteraction
- Efficacy
- Experiment
- ExperimentalOutput
- Fragment
- Gene
- GeneExpressionProfile
- GenomicSequence
- ImmuneResponse
- InactiveIngredient
- Information
- Intervention *
- Market
- MarketOpportunity
- MaterialEntity *
- Measure *
- Metabolism *
- MolecularStructure
- Observation *
- Outcome
- Patent
- Pathway
- Patient
- PatientDiagnosis
- PatientPrognosis
- Payer
- Person
- Pharmacology
- Pharmacophore
- Phenotype *
- Polypharmacology
- Population
- Project
- Protein *
- Receptor
- Referral
- Regulator
- Resource
- Risk
- Role *
- SNP
- Sample *
- Scaffold
- SideEffect *
- Signaling *
- Solution *
- Symptom *
- Synthesis
- Target *
- Test *
- Therapy
- TherapyCostBenefit
- Tissue *
- Toxicology
- Treatment *
- TreatmentManagementPlan
- Unit *
[EP: 27 Classes/concepts originally identified at 2009/04/30 F2F and reviewed in 2009/05/14 TC are marked by *.]
[MD: See TMO Review MD ]
Relations
- a drug participates in a treatment for a disease
- a compound has the function of an active ingredient in a drug
- a population has a statistically-significant SNP
- a population has a predisposition to a disease
- a patient suffers an adverse event in the context of a treatment
See some notes on these examples.